ELLEN LEE: Open Payments
NPI 1962046714 · SANTA MONICA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$975 in 48 payments from 15 companies in 2025. Trend: 2023 $1,832 · 2024 $2,310 · 2025 $975
Food & beverage: $975
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 23 | $376 |
| ABBVIE INC. | 5 | $99 |
| GENZYME CORPORATION | 2 | $91 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $63 |
| Medimetriks Pharmaceuticals, Inc. | 2 | $51 |
| Galderma Laboratories, L.P. | 2 | $44 |
| ANI Pharmaceuticals, Inc. | 2 | $42 |
| Organon LLC | 3 | $39 |
| Janssen Biotech, Inc. | 1 | $36 |
| E.R. Squibb & Sons, L.L.C. | 1 | $27 |
Products named: OTEZLA, DUPIXENT, BOTOX, Winlevi, Genadur, AKLIEF, VTAMA, TREMFYA.
Industry payments across CA — which companies pay providers there.
